Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Aura Biosciences, Inc. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2026-06-11 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-11
Exact text from the filing
Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Votes For Votes Against Abstentions 52,752,601 17,348 14,795 There were zero broker non-votes regarding this proposal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Aura Biosciences, Inc. shareholders approved Election of Class II Directors at the 2026-06-11 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-11
Exact text from the filing
Proposal 1 - Election of Directors The Company’s stockholders elected the two (2) director nominees below to the Company’s Board of Directors as Class II directors to serve until the 2029 Annual Meeting of Stockholders of the Company and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Director Nominee Votes For Votes Withheld Broker Non-Votes David Johnson 34,542,193 6,628,297 11,614,254 Teresa Marie Bitetti 40,526,332 644,158 11,614,254
View on SEC.gov